Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) Q2 2024 Earnings

ACTU·Reported September 24, 2024·Before market open

Diluted EPS came in at $-4.20.

Diluted EPS
$-4.20
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001683168-24-006623

Financial Snapshot

Trailing eight quarters through Q2 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Actuate Therapeutics, Inc.'s Q2 2024 earnings report.

Actuate Therapeutics, Inc. (ACTU) reported Q2 2024 earnings on September 24, 2024 before market open.

Actuate Therapeutics, Inc. reported diluted EPS of $-4.20 for Q2 2024.

You can read the 10-Q periodic report (0001683168-24-006623) directly on SEC EDGAR. The filing index links above go to sec.gov.